Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/13432
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.otherProducción Científica UCH 2021-
dc.contributor.otherUCH. Departamento de Ciencias Biomédicas-
dc.contributor.otherUCH. Departamento de Medicina y Cirugía-
dc.creatorAkselsen, A.B.-
dc.creatorSheth Shah, Chirag Chandrakant.-
dc.creatorVeses Jiménez, Verónica.-
dc.date2021-
dc.date.accessioned2022-03-01T05:00:45Z-
dc.date.available2022-03-01T05:00:45Z-
dc.date.issued2021-12-24-
dc.identifier.citationAkselsen, A.B., Sheth, C.C. & Veses, V. (2021). Efficacy of empiric antibiotic treatment of late-onset neonatal sepsis caused by "Enterobacteriaceae" : a systematic review. Letters in Applied Microbiology, Online Version (24 dec.). DOI: https://doi.org/10.1111/lam.13640-
dc.identifier.issn0266-8254-
dc.identifier.issn1472-765X (Electrónico)-
dc.identifier.urihttp://hdl.handle.net/10637/13432-
dc.descriptionEste artículo se encuentra disponible en la siguiente URL: https://sfamjournals.onlinelibrary.wiley.com/doi/10.1111/lam.13640-
dc.description.abstractNeonatal sepsis is a serious condition, where an adequate empiric antibiotic treatment is crucial. The objective of this systematic review is to assess whether the World Health Organization’s recommended treatment regime remains applicable for late-onset neonatal sepsis caused by Enterobacteriaceae, in the time of increased antimicrobial resistance. PubMed was searched for articles from 2009 to 2020. A total of 49 articles were eligible for inclusion. The review was carried out in accordance with PRISMA guidelines. For Klebsiella spp. 100, 68 and 63% of the studies found sensitivity to ampicillin, gentamicin and third-generation cephalosporin in <50% of the isolates. For Escherichia coli, the corresponding values were 88, 50 and 42% respectively, whilst for Enterobacter spp. 100, 70 and 94% of the studies found <50% sensitivity to these antibiotics. Overall, there is low sensitivity to all agents in the WHO’s recommended empiric treatment regimes (WHO recommends ampicillin plus gentamicin as first-line treatment and third-generation cephalosporin as second-line treatment). A revised guideline for empiric antibiotic treatment of neonatal sepsis is urgently needed due to the increased threat of antimicrobial resistant Enterobacteriaceae causing neonatal sepsis.-
dc.formatapplication/pdf-
dc.language.isoen-
dc.publisherSociety for Applied Microbiology-
dc.publisherJohn Wiley & Sons-
dc.relation.ispartofLetters in Applied Microbiology, Online Version (24 dec. 2021).-
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectNiños recién nacidos - Enfermedades - Tratamiento.-
dc.subjectNewborn infants - Diseases - Treatment.-
dc.subjectSepsis neonatal - Farmacoterapia.-
dc.subjectDrug resistance in Enterobacter.-
dc.subjectNeonatal sepsis - Chemotherapy.-
dc.subjectAntibiotics.-
dc.subjectEnterobacterias - Resistencia a los medicamentos.-
dc.subjectAntibióticos.-
dc.titleEfficacy of empiric antibiotic treatment of late-onset neonatal sepsis caused by "Enterobacteriaceae" : a systematic review-
dc.typeArtículo-
dc.identifier.doihttps://doi.org/10.1111/lam.13640-
Aparece en las colecciones: Dpto. Ciencias Biomédicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Efficacy_Akselsen_LIAM_2021.pdf285,41 kBAdobe PDFVisualizar/Abrir



Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.